Optical frequency domain imaging-guided versus intravascular ultrasound-guided percutaneous coronary intervention for acute coronary syndromes: the OPINION ACS randomised trial
EuroIntervention · 2024-09 · 20 (17) · e1086-e1097
DOI: 10.4244/eij-d-24-00314 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift EuroIntervention, 2024-09. Verfasst von Hiromasa Otake und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan. Hauptthemen laut MEDLINE: Ultrasonography, Interventional, Percutaneous Coronary Intervention, Acute Coronary Syndrome, Drug-Eluting Stents. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND: The clinical benefits of optical frequency domain imaging (OFDI)-guided percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS) remain unclear. AIMS: We sought to compare intravascular ultrasound (IVUS)- and OFDI-guided PCI in patients with ACS. METHODS: OPINION ACS is a multicentre, prospective, randomised, non-inferiority trial that compared OFDI-guided PCI with IVUS-guided PCI using current-generation drug-eluting stents in ACS patients (n=158). The primary endpoint was in-stent minimum lumen area (MLA), assessed using 8-month follow-up OFDI. RESULTS: Patients presented with ST-segment elevation myocardial infarction (55%), non-ST-segment elevation myocardial infarction (29%), or unstable angina pectoris (16%). PCI procedural success was achieved in all patients, with comparably low periprocedural complications rates in both groups. Immediately after PCI, the minimum stent area (p=0.096) tended to be smaller for OFDI versus IVUS guidance. Proximal stent edge dissection (p=0.012) and irregular protrusion (p=0.03) were significantly less frequent in OFDI-guided procedures than in IVUS-guided procedures. Post-PCI coronary flow, assessed using corrected Thrombolysis in Myocardial Infarction frame counts, was significantly better in the OFDI-guided group than in the IVUS-guided group (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.
- Department of Cardiology, Tokyo Medical University, Hachioji Medical Center, Tokyo, Japan.
- Division of Cardiology, Yokohama City University Medical Center, Yokohama, Japan.
- Division of Cardiology, Tokai University School of Medicine, Isehara, Japan.
- Division of Cardiology, Department of Internal Medicine, Iwate Medical University, Morioka, Japan.
- Division of Cardiology, Bell-land General Hospital, Sakai, Japan.
Zitieren
APA
Otake, H., Kubo, T., Hibi, K., Natsumeda, M., Ishida, M., Kataoka, T., Takaya, T., Iwasaki, M., Sonoda, S., Shinke, T., Nakazawa, G., Takahashi, Y., Ioji, T., Akasaka, T., & Investigators, O. A. (2024). Optical frequency domain imaging-guided versus intravascular ultrasound-guided percutaneous coronary intervention for acute coronary syndromes: the OPINION ACS randomised trial. EuroIntervention, 20(17), e1086-e1097. https://doi.org/10.4244/eij-d-24-00314
Vancouver
Otake H, Kubo T, Hibi K, Natsumeda M, Ishida M, Kataoka T, et al. Optical frequency domain imaging-guided versus intravascular ultrasound-guided percutaneous coronary intervention for acute coronary syndromes: the OPINION ACS randomised trial. EuroIntervention. 2024;20(17):e1086-e1097. doi:10.4244/eij-d-24-00314
BibTeX
@article{Otake2024,
author = {Otake, Hiromasa and Kubo, Takashi and Hibi, Kiyoshi and Natsumeda, Makoto and Ishida, Masaru and Kataoka, Toru and Takaya, Tomofumi and Iwasaki, Masamichi and Sonoda, Shinjo and Shinke, Toshiro and Nakazawa, Gaku and Takahashi, Yu and Ioji, Tetsuya and Akasaka, Takashi and Investigators, Opinion Acs},
title = {Optical frequency domain imaging-guided versus intravascular ultrasound-guided percutaneous coronary intervention for acute coronary syndromes: the OPINION ACS randomised trial},
journal = {EuroIntervention},
year = {2024},
volume = {20},
number = {17},
pages = {e1086--e1097},
doi = {10.4244/eij-d-24-00314}
}
EUVIMED